Branch Therapeutics, Inc.
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
Branch Therapeutics, Inc. - overview
Established
2024
Location
Houston, TX, US
Primary Industry
Biotechnology
About
Founded in 2024 and based in Texas, US, Branch Therapeutics, Inc. operates as a drug discovery company that offers drugs that can overcome cancer progression and drug resistance. In May 2025, Branch Therapeutics raised USD 4 million in seed funding from GKCC, LLC. Branch Therapeutics develops orally bioavailable and well-tolerated drugs to treat multiple cancer types, with a specific interest in targeting key drivers of colorectal cancer.
The company plans to use the funding to support the first phase of its clinical trials.
Current Investors
GKCC, LLC
Primary Industry
Biotechnology
Sub Industries
Biopharmaceuticals, Oncology/Cancer Treatment, Pharmaceutical Research & Development
Verticals
Manufacturing
Company Stage
Angel & Seed
Total Amount Raised
Subscriber access only
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.